News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,243 Results
Type
Article (13766)
Company Profile (101)
Press Release (251376)
Section
Business (88040)
Career Advice (465)
Deals (15343)
Drug Delivery (67)
Drug Development (36602)
Employer Resources (49)
FDA (6291)
Job Trends (6197)
News (150209)
Policy (14029)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Accelerated approval (2)
Adcomms (6)
Allergies (32)
Alliances (23214)
ALS (36)
Alzheimer's disease (390)
Antibody-drug conjugate (ADC) (37)
Approvals (6328)
Artificial intelligence (104)
Autoimmune disease (8)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (40)
Bladder cancer (19)
Brain cancer (15)
Breast cancer (74)
Cancer (585)
Cardiovascular disease (70)
Career advice (407)
Career pathing (11)
CAR-T (21)
Cell therapy (85)
Cervical cancer (4)
Clinical research (30882)
Collaboration (325)
Compensation (138)
Complete response letters (17)
COVID-19 (757)
CRISPR (19)
C-suite (117)
Cystic fibrosis (35)
Data (607)
Denatured (15)
Depression (9)
Diabetes (77)
Diagnostics (1317)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32079)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37410)
Executive appointments (359)
FDA (6689)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (205)
Gene editing (37)
Generative AI (8)
Gene therapy (100)
GLP-1 (339)
Government (1287)
Grass and pollen (2)
Guidances (15)
Healthcare (3564)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (12)
Infectious disease (790)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (13)
Intellectual property (45)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (178)
Leadership (3)
Legal (3430)
Liver cancer (19)
Lung cancer (79)
Lymphoma (52)
Machine learning (1)
Management (16)
Manufacturing (143)
MASH (31)
Medical device (1275)
Medtech (1277)
Mergers & acquisitions (9659)
Metabolic disorders (246)
Multiple sclerosis (20)
NASH (14)
Neurodegenerative disease (22)
Neuropsychiatric disorders (6)
Neuroscience (563)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (681)
Now hiring (7)
Obesity (140)
Opinion (118)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (44)
Partnered (7)
Patents (104)
Patient recruitment (28)
Peanut (10)
People (28878)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8037)
Phase II (13062)
Phase III (11730)
Pipeline (416)
Podcasts (46)
Policy (59)
Postmarket research (1401)
Preclinical (3211)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (158)
Real estate (2634)
Recruiting (17)
Regulatory (10090)
Reports (14)
Research institute (564)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (7)
Schizophrenia (35)
Series A (36)
Series B (11)
Service/supplier (3)
Sickle cell disease (31)
Southern California (696)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1627)
State (2)
Stomach cancer (3)
Supply chain (28)
Tariffs (10)
The Weekly (29)
United States (6905)
Vaccines (150)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Last 7 days (241)
Last 30 days (879)
Last 365 days (11959)
2025 (3098)
2024 (12501)
2023 (14246)
2022 (19558)
2021 (20068)
2020 (19033)
2019 (14887)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (54)
Arkansas (3)
Asia (20091)
Australia (2606)
California (1645)
Canada (874)
China (230)
Colorado (65)
Connecticut (65)
Delaware (53)
Europe (39370)
Florida (308)
Georgia (36)
Idaho (9)
Illinois (186)
India (15)
Indiana (129)
Iowa (1)
Japan (86)
Kansas (56)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (246)
Massachusetts (1424)
Michigan (28)
Minnesota (90)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (727)
New Mexico (7)
New York (482)
North Carolina (381)
North Dakota (2)
Northern California (681)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (416)
Puerto Rico (8)
Rhode Island (7)
South America (501)
South Carolina (2)
Southern California (696)
Tennessee (34)
Texas (219)
Utah (33)
Virginia (70)
Washington D.C. (29)
Washington State (112)
Wisconsin (14)
265,243 Results for "avadel pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
March 5, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
April 1, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
February 25, 2025
·
9 min read
Press Releases
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
17 min read
Press Releases
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
February 24, 2025
·
1 min read
Press Releases
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors
February 10, 2025
·
4 min read
Press Releases
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
January 22, 2025
·
2 min read
Avadel Pharmaceuticals to Present at Upcoming June 2024 Investor Conferences
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced that members of management will participate in the following upcoming investor conferences.
May 30, 2024
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 13, 2024
·
1 min read
Avadel Pharmaceuticals to Join Russell 3000® Index - June 27, 2024
Avadel Pharmaceuticals plc announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted Friday, May 24, 2024.
June 27, 2024
·
3 min read
1 of 26,525
Next
